Reggie Duerst
About
Reggie Duerst is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Reggie Duerst has authored 42 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 13 papers in Public Health, Environmental and Occupational Health and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Reggie Duerst's work include Hematopoietic Stem Cell Transplantation (26 papers), Acute Lymphoblastic Leukemia research (13 papers) and Acute Myeloid Leukemia Research (12 papers). Reggie Duerst is often cited by papers focused on Hematopoietic Stem Cell Transplantation (26 papers), Acute Lymphoblastic Leukemia research (13 papers) and Acute Myeloid Leukemia Research (12 papers). Reggie Duerst collaborates with scholars based in United States, Singapore and Russia. Reggie Duerst's co-authors include Morris Kletzel, David A. Jacobsohn, William Tse, Francisco Arguello, Raymond B. Baggs, Camille N. Abboud, Christopher Frantz, Alfred Rademaker, Louis S. Constine and Aaron P. Rapoport and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.
In The Last Decade
Reggie Duerst
40 papers receiving 881 citations
Peers
Reggie Duerst
François Deméocq France
Roberta H. Adams United States
Franz‐Martin Fink Austria
Brian G. Engelhardt United States
Patrick Boutard France
Shakila P. Khan United States
J.F. Seymour Australia
Kimikazu Yakushijin Japan
C. Annaloro Italy
Bengt Sallerfors Sweden
Citations per year, relative to Reggie Duerst Reggie Duerst (= 1×)
peers
François Deméocq
Countries citing papers authored by Reggie Duerst
Since
Specialization
Citations
This map shows the geographic impact of Reggie Duerst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reggie Duerst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reggie Duerst more than expected).
Fields of papers citing papers by Reggie Duerst
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Reggie Duerst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reggie Duerst. The network helps show where Reggie Duerst may publish in the future.
Co-authorship network of co-authors of Reggie Duerst
This figure shows the co-authorship network connecting the top 25 collaborators of Reggie Duerst. A scholar is included among the top collaborators of Reggie Duerst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reggie Duerst. Reggie Duerst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Broglie, Larisa, Alfred Rademaker, John P. Galvin, et al.. (2018). Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease. Hematology/Oncology and Stem Cell Therapy. 11(3). 169–174.
2.
Morris, Joan, Mattias Rudebeck, Steven Neudorf, et al.. (2016). Safety, Pharmacokinetics, and Efficacy of Palifermin in Children and Adolescents with Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Trial. Biology of Blood and Marrow Transplantation. 22(7). 1247–1256.
3.
Ward, Jessica, Morris Kletzel, Reggie Duerst, et al.. (2015). Single Daily Busulfan Dosing for Infants with Nonmalignant Diseases Undergoing Reduced-Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(9). 1612–1621.
4.
Ballen, Karen K., John P. Klein, Tanya L. Pedersen, et al.. (2011). Relationship of Race/Ethnicity and Survival after Single Umbilical Cord Blood Transplantation for Adults and Children with Leukemia and Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation. 18(6). 903–912.
5.
Verneris, Michael R., Mary Eapen, Reggie Duerst, et al.. (2010). Reduced-Intensity Conditioning Regimens for Allogeneic Transplantation in Children with Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 16(9). 1237–1244.
6.
McNeer, Jennifer L., et al.. (2009). Early Elevation of C-Reactive Protein Correlates with Severe Infection and Nonrelapse Mortality in Children Undergoing Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(3). 350–357.
7.
Jacobsohn, David A., William Tse, Stanley Chaleff, et al.. (2009). High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event‐free survival. British Journal of Haematology. 146(6). 669–674.
8.
Kadota, Richard, Donald H. Mahoney, John Doyle, et al.. (2008). Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma. Pediatric Blood & Cancer. 51(5). 675–678.
9.
Birch, Jennifer, Sarah L. Chamlin, Reggie Duerst, & David A. Jacobsohn. (2008). Mycoplasma pneumoniae and atypical Stevens–Johnson syndrome in a hematopoietic stem cell transplant recipient. Pediatric Blood & Cancer. 50(6). 1278–1279.
10.
Burke, Michael J., David Walterhouse, David A. Jacobsohn, Reggie Duerst, & Morris Kletzel. (2007). Tandem high‐dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high‐risk Ewing family tumors. Pediatric Blood & Cancer. 49(2). 196–198.
11.
Melín‐Aldana, Héctor, et al.. (2006). Hepatitic pattern of graft versus host disease in children. Pediatric Blood & Cancer. 49(5). 727–730.
12.
Kletzel, Morris, David A. Jacobsohn, & Reggie Duerst. (2006). Pharmacokinetics of a Test Dose of Intravenous Busulfan Guide Dose Modifications to Achieve an Optimal Area Under the Curve of a Single Daily Dose of Intravenous Busulfan in Children Undergoing a Reduced-Intensity Conditioning Regimen with Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 12(4). 472–479.
13.
Schneiderman, Jennifer, Reggie Duerst, Kim Campbell, et al.. (2006). Reduced Intensity Conditioning (RIC) and Hematopoietic Stem Cell Transpalntation (HSCT) Utilizing Extracorporeal Photopheresis (ECP), Fludarabine, and Targeted Dose Busulfan in Children.. Blood. 108(11). 5307–5307.
14.
Kletzel, Morris, David A. Jacobsohn, William Tse, & Reggie Duerst. (2005). Reduced intensity transplants (RIT) in pediatrics: A review. Pediatric Transplantation. 9(s7). 63–70.
15.
Jacobsohn, David A., et al.. (2005). Favorable Outcome for Infant Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(12). 999–1005.
16.
Kletzel, Morris, David A. Jacobsohn, William Tse, & Reggie Duerst. (2004). Single Daily Dose of I.V. Busulfan (BU) in Pediatric Patients. Feasibility, Pharmacokinetics (PK) and Toxicity.. Blood. 104(11). 1151–1151.
17.
Abboud, Camille N., et al.. (1991). Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage‐mediated antibody dependent cellular cytotoxicity. Journal of Cellular Biochemistry. 45(4). 381–390.
18.
Duerst, Reggie, et al.. (1991). Cells of the J774 macrophage cell line are primed for antibody-dependent cell-mediated cytotoxicity following exposure to γ-irradiation. Cellular Immunology. 136(2). 361–372.
19.
Arguello, Francisco, et al.. (1990). Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer. 65(1). 98–106.
20.
Frantz, Christopher, et al.. (1986). A Monoclonal Anti-Neuroblastoma Antibody That Discriminates Between Human Nonhematopoietic and Hematopoietic Cell Types. Hybridoma. 5(4). 297–306.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by François Deméocq Breakdown of academic impact, for papers by Roberta H. Adams Breakdown of academic impact, for papers by Franz‐Martin Fink Breakdown of academic impact, for papers by Brian G. Engelhardt Breakdown of academic impact, for papers by Patrick Boutard Breakdown of academic impact, for papers by Shakila P. Khan Breakdown of academic impact, for papers by J.F. Seymour Breakdown of academic impact, for papers by Kimikazu Yakushijin Breakdown of academic impact, for papers by C. Annaloro Breakdown of academic impact, for papers by Bengt Sallerfors